VijayNambiMD

Adult Congenital Heart Disease

Associate Professor, Medicine, Baylor College of Medicine

Dr. Nambi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1504 Taub Loop
Houston, TX 77030
Phone+1 713-873-2000

Fax+1 713-798-1144

Baylor College of MedicineFellowship, Cardiovascular Disease, 2003 - 2006
Cleveland Clinic FoundationResidency, Internal Medicine, 1999 - 2002
University of Illinois College of Medicine at ChicagoInternship, Internal Medicine, 1998 - 1999
Madras Medical CollegeClass of 1998

PubMed

Adipokines and Transitions in Metabolic Health Over Time: The Atherosclerosis Risk In Communities (ARIC) Study.
Bige Ozkan, Sui Zhang, Justin B Echouffo-Tcheugui, Roberta Florido, Vijay Nambi
The Journal of Clinical Endocrinology and Metabolism. 2025-01-07
The future of hypertension pharmacotherapy: Ongoing and future clinical trials for hypertension.
Taha Mansoor, Fatima Farrukh, Subaina N Khalid, Dmitry Abramov, Erin D Michos
Current Problems in Cardiology. 2025-01-01
Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD.
L Parker Gregg, Peter A Richardson, Vijay Nambi, Laura A Petersen, Michael E Matheny
Journal of the American Society of Nephrology. 2025-01-01

Journal Articles

Associations Between Carotid Artery Plaque Burden, Plaque Characteristics, and Cardiovascular Events
Salim S Virani, Vijay Nambi, Christie M Ballantyne, JAMA Cardiology
Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index
Rohan Khera, Vijay Nambi, Stephen L Seliger, Monika M Safford, Robert J Mentz, Donald M Lloyd-Jones, Ian J Neeland, JAMA Network Open
Original Investigation Remnant-like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease
Christie M Ballantyne, Anum Saeed, Vijay Nambi, Salim S Virani, Cameron S Guild, ScienceDirect

Lectures

Safety of Evolocumab in People Living with HIV Infection an Important First Step
American Heart Association, Scientific Sessions 2011, Orlando, Florida, USA
Safety of Evolocumab in People Living with HIV Infection an Important First Step
Scientific Sessions 2011, Orlando, Florida, USA
So You Know Your Lipids! Let's Ask Some Questions and Discuss Some Cases
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Safety of Evolocumab in People Living with HIV Infection an Important First StepMay 2020

Uptick in Natriuretic Peptides with Long-Term Serial Testing Predicts New Heart FailureFebruary 14th, 2023
Uptake Uncertain for Potent New LDL-Lowerer InclisiranJanuary 26th, 2022
As COVID-19 Drags on, the Cardiology Fallout May Haunt for YearsDecember 16th, 2021
Join now to see all

Improving Cardiovascular Risk Assessment Using Ultrasound ImagingNational Heart, Lung, And Blood Institute2009–2011